Study examines how severely injured patients fare in the ICU
NCT ID NCT07482267
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks back at the records of 417 adults with severe injuries (polytrauma) who were treated in the intensive care unit between 2020 and 2025. The goal is to describe their care, how long they stayed, and their survival. No new treatment is being tested; instead, researchers hope to learn from past cases to improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 417 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patients with a polytrauma admitted to the ICU between 01/01/2020 and 31/12/2025
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All patients with a polytrauma admitted to the ICU between 01/01/2020 and 31/12/2025 Exclusion Criteria: * Younger than 18 years of age
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Polytrauma patients are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jessa Hospital
Hasselt, 3500, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.